EMP3 as a prognostic biomarker correlates with EMT in GBM
Abstract Background Glioblastoma (GBM) is the most aggressive malignant central nervous system tumor with a poor prognosis.The malignant transformation of glioma cells via epithelial-mesenchymal transition (EMT) has been observed as a main obstacle for glioblastoma treatment. Epithelial membrane pro...
| Published in: | BMC Cancer |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-01-01
|
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12885-023-11796-0 |
